CORTICAL SEROTONIN RECEPTOR SUBTYPES AFTER LESION OF ASCENDING CHOLINERGIC NEURONS IN RAT

被引:16
作者
CROSS, AJ [1 ]
DEAKIN, JFW [1 ]
机构
[1] UNIV MANCHESTER, DEPT PSYCHIAT, MANCHESTER M13 9PL, LANCS, ENGLAND
关键词
D O I
10.1016/0304-3940(85)90587-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonin (5-HT) S1 and S2 receptors were studied in rat cortex after lesion of the ascending cholinergic systems by injection of ibotenic acid into the nucleus basalis. The lesions produced a large (56%) decrease in choline acetyltransferase activity with no change in markers of .gamma.-aminobutyric acid, dopamine and 5-HT containing neurones. Lesions of the ascending cholinergic neurones were accompanied by a loss of 5-HT S1 receptor binding sites with no change in S2 receptors. These results suggest that a proportion of S1 receptors may be associated with cholinergic terminals.
引用
收藏
页码:261 / 265
页数:5
相关论文
共 20 条
[1]   BIOCHEMICAL ASSESSMENT OF SEROTONERGIC AND CHOLINERGIC DYSFUNCTION AND CEREBRAL ATROPHY IN ALZHEIMERS-DISEASE [J].
BOWEN, DM ;
ALLEN, SJ ;
BENTON, JS ;
GOODHARDT, MJ ;
HAAN, EA ;
PALMER, AM ;
SIMS, NR ;
SMITH, CCT ;
SPILLANE, JA ;
ESIRI, MM ;
NEARY, D ;
SNOWDON, JS ;
WILCOCK, GK ;
DAVISON, AN .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (01) :266-272
[2]  
BOWEN DM, 1979, LANCET, V1, P11
[3]   SEROTONIN RECEPTOR CHANGES IN DEMENTIA OF THE ALZHEIMER TYPE [J].
CROSS, AJ ;
CROW, TJ ;
FERRIER, IN ;
JOHNSON, JA ;
BLOOM, SR ;
CORSELLIS, JAN .
JOURNAL OF NEUROCHEMISTRY, 1984, 43 (06) :1574-1581
[4]   THE CONCURRENT ESTIMATION OF THE MAJOR MONOAMINE METABOLITES IN HUMAN AND NON-HUMAN PRIMATE BRAIN BY HPLC WITH FLUORESCENCE AND ELECTROCHEMICAL DETECTION [J].
CROSS, AJ ;
JOSEPH, MH .
LIFE SCIENCES, 1981, 28 (05) :499-505
[5]   STUDIES ON NEUROTRANSMITTER RECEPTOR SYSTEMS IN NEOCORTEX AND HIPPOCAMPUS IN SENILE DEMENTIA OF THE ALZHEIMER-TYPE [J].
CROSS, AJ ;
CROW, TJ ;
JOHNSON, JA ;
PERRY, EK ;
PERRY, RH ;
BLESSED, G ;
TOMLINSON, BE .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1984, 64 (02) :109-117
[9]  
JOHNSTON MV, 1981, EXP BRAIN RES, V43, P159
[10]  
LEYSEN JE, 1982, MOL PHARMACOL, V21, P301